Mesoblast Limited (MESO) Receives Average Recommendation of “Hold” from Brokerages
Shares of Mesoblast Limited (NASDAQ:MESO) have earned a consensus rating of “Hold” from the nine ratings firms that are covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a sell recommendation, two have issued a hold recommendation and five have given a buy recommendation to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $13.14.
A number of research analysts recently commented on MESO shares. BidaskClub downgraded Mesoblast Limited from a “hold” rating to a “sell” rating in a research note on Wednesday, July 12th. Credit Suisse Group set a $11.00 price objective on Mesoblast Limited and gave the stock a “hold” rating in a research note on Tuesday, July 18th. Maxim Group set a $14.00 price objective on Mesoblast Limited and gave the stock a “buy” rating in a research note on Wednesday, August 16th. Cantor Fitzgerald set a $20.00 price objective on Mesoblast Limited and gave the stock a “buy” rating in a research note on Wednesday, August 16th. Finally, Oppenheimer Holdings, Inc. started coverage on Mesoblast Limited in a research note on Thursday, August 31st. They set an “outperform” rating and a $16.00 price objective for the company.
Shares of Mesoblast Limited (NASDAQ MESO) opened at 5.50 on Friday. The firm’s market capitalization is $467.19 million. Mesoblast Limited has a one year low of $4.01 and a one year high of $12.50. The company’s 50 day moving average price is $6.06 and its 200 day moving average price is $7.77.
COPYRIGHT VIOLATION NOTICE: This story was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this story on another publication, it was stolen and republished in violation of United States & international trademark & copyright laws. The correct version of this story can be accessed at https://www.americanbankingnews.com/2017/10/27/mesoblast-limited-meso-receives-average-recommendation-of-hold-from-brokerages.html.
Mesoblast Limited Company Profile
Receive News & Ratings for Mesoblast Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast Limited and related companies with MarketBeat.com's FREE daily email newsletter.